Increased Pharmaceutical Research and Growing Patient Population to Drive Global Clinical Trial Management System Market

Clinical trial management system (CTMS) is an end-to-end software solution for planning, development, execution, and charting of clinical trials, which also includes participant information, trial and registration deadlines, and other landmark events.CTMS helps research centers and life sciences organizations attain efficacy and enhanced productivity of clinical trials by facilitating and managing clinical trials. Integrating CTMS with health information systems (HIS) leads to accuracy and economic benefits such as time and human resource saving, one of the primary factors to drive growth of the CTMS market.Additionally, high incidence of diseases has led to increased R&D activities in pharmaceutical, bio sciences, and clinical research sectors, which is offering several opportunities for the CTMS market. The global CTMS market was valued at US$844 million in 2013 and will exhibit an impressive 14% CAGR from 2013 to 2019 to reach US$1848.5 million in 2019.

Browse Full Global Clinical Trial Management System Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html

Software Sub-Segment to Dominate Global Clinical Trial Management Systems Market

The CTMS market is segmented on the basis of delivery modes of CTMS solutions, end users, types of CTMS solutions, components of CTMS solutions, and regional markets.Web-based CTMS solution delivery accounts for the highest revenue generation in the CTMS market. Of all the end users, the pharmaceutical sector accounts for the largest share of the CTMS market. On the basis of components of CTMS solutions, the software segment accounts as the lead revenue generator. The software segment of the market was valued at US$585 million in 2013 and is expected to reach US$1,274.2 million in 2019, growing at a healthy 13.9% CAGR between 2013 and 2019.

State-Funded Clinical Trials and Research to Allow U.S. to Lead Global CTMS Market

In terms of geography, North America accounts as the most active regional market in the overall CTMS market. This is due to the fact that North America has traditionally been supportive to clinical trials and clinical trials in the U.S. are being funded by the National Institute of Health (NIH), academic institutions, government agencies, and healthcare organizations. As per statistics by the U.S. National Institute of Health, approximately 56,981 clinical trials were conducted in the U.S. in 2011.The North American clinical trial management system market will be valued at US$1107.5 million in 2019, increasing from US$514.4 million in 2013, exhibiting a CAGR of 13.6% from 2013 to 2019.

Browse Full Press Release: http://www.transparencymarketresearch.com/pressrelease/clinical-trial-management-systems-market.htm

Improved Drug Patent Expiration Laws to Propel Asia Pacific CTMS Market

In Europe, mainly in Central European and East European countries, bio sciences and pharmaceutical companies receive abundant support to conduct clinical trials. The CTMS market has consequently grown considerably in the early parts of the ongoing decade and is expected to stay on a strong growth trajectory in the coming years.However, Asia Pacific is poised to be the fastest growing regional segment of the clinical trial management systems market. Escalated medical research and development in the pharmaceutical sector has led to adoption of CTMS in the region. Moreover, improved industry regulatory framework and patent expiration statutes in several countries such as China, India, and Japan have contributed significantly to the growth of the CTMS market in Asia Pacific.Some of the leading companies in the global clinical trial management system market are Oracle Corporation, Merge Healthcare, PAREXEL, and Medidata Solution. Other players offering services in the market are BioClinica, eClinforce, Forte Research, MedNet Solutions, Bio-Optronics, and DSG.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=544

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research

Transparency Market Research, a U.S.-based market intelligence company, recently published a report about the global life sciences BPO market to its report offering. According to the data presented in the report, the global life sciences BPO market is expected to be valued at US$596.0 billion by 2019, growing at a stunning CAGR of 21.5% from its value of US$152.5 billion in 2012. The report, titled “Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, is available for sale on the company website.The TMR study report observes that increased pressure from regulatory agencies, stringent rules for clinical trials, rising costs of R&D activities, and technological advancement has forced many pharmaceutical, biotechnology, and life science companies to outsource production and R&D activities. The key players in the life sciences find outsourcing to be a viable alternative that saves cost and time without affecting the competitive advantage in the market.

Browse the full Life Sciences BPO Market Report at http://www.transparencymarketresearch.com/life-sciences-bpo-market.html

This growth in outsourcing is driving the life sciences BPO market globally. Currently, new strategies for outsourcing are developed for almost every stage of the manufacturing and research process, which is boosting the life sciences BPO market. For example, in the research area for drug discovery a cross-functional, completely integrated outsourcing model is employed. Other areas of research driving the life sciences BPO market are gene-silencing, proteomics, and genomics for the identification of targets and validation of targets for complex diseases.Globally, the life sciences BPO market comprises contract research organizations (CROs), contract manufacturing organizations (CMOs), and others that include contract sales organizations (CSO). As per the TMR report, CMOs held the largest share of the life sciences BPO market in 2012, and are projected to exhibit the highest growth rate during the forecast period.

Browse the full Press Release:http://www.transparencymarketresearch.com/pressrelease/life-sciences-bpo-market.htm

The CMOs segment of the life sciences BPO market is spurred owing to growing demand for generic drugs and increased budgets for R&D activities set by life sciences companies. Additionally, growing expiry of blockbuster drug patents and higher adoption of new technologies is also boosting the life sciences BPO market.According to geographical segmentation, the global life sciences BPO market is classified as Europe, Rest of the World (RoW), North America, and Asia Pacific. The TMR study report finds North America to constitute the largest regional market for life sciences BPO in 2012. However, Asia Pacific is projected to witness the highest growth rate, more than 21%, in the global life sciences BPO market during the forecast period.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1782

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Government Incentive Programs to Boost the E-Prescribing Market

E-Prescribing is the system to broadcast information related to prescription among prescriber, dispenser, and pharmacy benefit manager electronically that allows a doctor and nurse to broadcast a new prescription electronically when any error in medication takes place at any stage in pharmacy operations. The global E-Prescribing market was worth US$111.2 million in terms of revenue in 2009. The market expanded itself to US$203.4 million in 2012, rising at 22.3% CAGR from 2009 to 2012. In 2013, the market was valued at US$250.2 million and is estimated to reach US$887.8 at 23.5% CAGR from 2013 to 2019.

Browse Full Global E-Prescribing Market Report With Complete TOC @ http://www.transparencymarketresearch.com/e-prescribing-market.html

The E-Prescribing system is used in a number of applications, which includes preparation of complete medication list, complete information of formulary, data security checks, and patient chronological data. These highly developed features of E-Prescribing are some of the main factors that drive the market. In addition to these, enhanced healthcare and medical infrastructure has resulted in the rise in demand for E-Prescribing system. However, increasing cost of E-Prescribing system and lack of the privacy and security of patient create hindrances in the growth of E-Prescribing market. Lack of high-speed broadband facilities and IT professionals in rural areas are also some of the key restraints for the E-Prescribing market.

Surescripts, a countrywide health information network, recently reported that more than 1 billion prescriptions were sent electronically in the U.S.A in 2013. It was 788 million in 2012.

E-Prescribing Market - Analyzing the Driving Factors

The E-Prescribing market is analyzed on the basis of various segments, such as products, components, delivery, usage, end-user applications, and regional markets.

Browse Full Press Release :http://www.transparencymarketresearch.com/pressrelease/e-prescribing-market.htm

By product type, the E-Prescribing market is segmented into stand-alone systems and integrated systems. eClinicalWorks and Cerner Corporation are the top companies in the stand-alone market for eRx systems, while Practice Fusion and Athena Health are the major players of the integrated E-Prescribing market.

By component, the market is divided into hardware, software, and services. The services market is the fastest developing segment since training, deployment, and consultation of IT services is of main concern to the medical and healthcare industry. This is majorly because healthcare providers are not well aware with technology and its usage and require assistance of IT professionals and trained personnel to arrange systems and operate them.

Based on delivery, the market is classified into mode licensed (on-premise), web-hosted, and cloud hosted. This market is led by web-hosted IT providers such as Practice Fusion, Cerner Corporation, and Emdeon.

Similarly, on the basis of usage, it is categorized into mode PC-based and hand-held devices.

By end-user application, hospitals and office-based physicians are the two segments of the E-Prescribing market.

Geographically, the E-Prescribing market is divided into three categories, North America, Europe, and Asia. Europe accounts for the largest market share in the global E-Prescribing market. Integrated system is the biggest E-Prescribing system and web-based E-Prescribing system is the biggest delivery mode. Software is the main part of the E-Prescribing system. Additionally, hand-held device usage mode holds the largest market share and hospital holds the largest share in end user segment of E-Prescribing market.

In terms of development, North America is the fastest developing region for E-Prescribing market. Services are the top most emerging elements of the E-Prescribing system. Cloud-based system of E-Prescribing is the fastest developing delivery mode and office-based physician is the top most end-user of E-Prescribing market.

E-Prescribing Market - Major Companies

The key companies of the E-Prescribing market are Allscripts, eClinicalWorks, Practice Fusion, Inc., DrFirst, Emdeon, Henry Schein, Inc., HealthFusion, Inc., Surescripts, Cerner Corporation, and athenahealth, Inc.

Application of electronic medical accounts in accordance with E-Prescribing system has enormous opportunities for the development of the E-Prescribing market.

Request a Sample of this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=929

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Bioinformatics: A fusion of Computers and Biological Data:Transparency Market Research

Bioinformatics refers to an interdisciplinary approach to store, retrieve, organize and analyze biological and genetic data. A major part of this field comprises of the activity of developing software tools to generate and process useful biological data.

Browse Full Bioinformatics Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/bioinformatics-market.html

Bioinformatics is not to be confused with biological computation. While bioinformatics simply makes use of computers for the better understanding of biology can its related concepts, biological computation refers to the subfield of computer engineering that seeks to build biological computers by using biology and bioengineering concepts.

Bioinformatics is, however, much similar to computational biology, only the scale of application and study differs - bioinformatics studies biological data on a molecular scale with keen attention to details while computational biology studies biological data by building large-scale theoretical models of biological systems and studying them with an abstract view to expand our knowledge about them.

Bioinformatics makes use of various laws of computer science, engineering, applied math and statistics to conceptualize biology in terms of bio-molecules (RNAs, DNAs) and process the resulting data in various ways in attempt to decode the code of life.

The use of computers has made the process of reading complex biological data much faster and efficient than before. Huge databases and information systems are used to store and retrieve data; analytical algorithms in soft computing, artificial intelligence, data mining, image processing, etc. are used to analyze data; algorithms in turn depend on theoretical principles of statistics, applied and discrete mathematics, system theory and control theory. As such, bioinformatics uses a good mix of many fundamental principles as well as many applied theories and sciences to manage biological data.

Browse Full Press Release Report: http://www.transparencymarketresearch.com/pressrelease/global-bioinformatics-market.htm

Aims of bioinformatics

Bioinformatics has threefold aims. Firstly, it manages data in such a manner that it becomes quite easy for researchers to access existing data and submit new data as they are produced. While data storage is an essential task for data management, any kind of data is practically useless unless it is analyzed. Thus, the purpose of bioinformatics is extended further because of data analysis.

The second aim of bioinformatics is to develop systems and tools to analyze data properly. For instance, after having a particular protein sequenced, it is necessary to compare it with a previously sequenced sample. To do this, a program a lot more advanced than a simple text-based comparator is required to understand the biological significance between the differences as well as the similarities in the two sequences studied. Bioinformatics aims at development of such complex tools by using expertise in computational theory and biological understanding.

The third aim of bioinformatics is to analyze the biological data through the use of complex mechanisms and convert the data in such a form that is biologically meaningful. In traditional biological studies, examining individual systems and comparison with only a few related fields was possible. But Bioinformatics has allowed the global analysis and comparison of data available from a variety of fields. Clearly, developing methods to assess the differences between different varieties of biomolecules and identifying similarities over a wide range of dissimilar sources is an essential aspect of managing the huge volumes of data and thus of bioinformatics.

Conclusion:

This field, which was originally developed for the analysis of biological sequences, has now grown to encompass a wide range of areas such as genomics, gene expression, structural biology, etc.

Almost all studies in bioinformatics underpin to two basic approaches. First is that of comparing and grouping biological data according to biological similarities and the second that of analyzing one type of data and using the information thus obtained to infer the observations from some other type of data.

These two approaches in bioinformatics are reflected in the main aims of the field that are storing, organizing and analyzing biological data with keen attention to details on a molecular scale. This has allowed bioinformatics in providing not only greater depth but also adding the dimension of breadth to biological investigations.

This has essentially provided us the opportunity to study individual systems in details with the ones that are related to reveal the similar traits between some systems and underline some unusual features, if any, which are unique

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=656

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector — such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Mr. Nachiket Ghumare

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Healthcare Information Systems Market to Post 7.1% CAGR from 2013–2019 with Progression of Integrated Healthcare Systems

The deepening interest in integrated healthcare systems will benefit the global healthcare information systems market, leading it to achieve a compounded annual growth rate (CAGR) of 7.1% between 2013 and 2019, says Transparency Market Research in its latest report. The report, titled ‘Healthcare Information System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019’ states that the market, will reach US$53.2 billion by 2019, growing strongly from its 2013 value of US$35.1 billion. The growth of the market is also propelled by an increase in the healthcare costs.The other market forces pinned down by the report are: An expansion in the aging population base, supportive government initiatives, and higher investments by companies in the healthcare IT market. In contrast, aspects that will impede the growth of the healthcare information systems market are identified as: A dearth of skilled and experienced professionals, high investment and maintenance costs of healthcare informatics, and interoperability glitches.

Browse the full Healthcare Information System Market Report at http://www.transparencymarketresearch.com/healthcare-information-system.html

Even as companies in the market try to address and alleviate the drawbacks of healthcare informatics, there are some remunerative opportunities that are already on the horizon. The foremost among these is wireless and cloud technology for healthcare informatics. These developments are the result of a paradigm shift from manual processes to computerized and automated processes. The burgeoning adoption of electronic health records and the growing use of mobile devices for monitoring and alerts is expected to create promising avenues for the growth of the healthcare information systems market.

An external trend that directly impacts the growth rate of the global healthcare information systems market is the increasing adoption of home health monitoring systems – the use of such systems was estimated to be 2.8 million in 2012. Wireless medical devices, too, are soon become a healthcare standard. Research studies state that in 2014, about 5.7 million patients were monitored via wireless medical devices.The report segments the healthcare information systems market by application mode as: Pharmacy information system, hospital information system, and laboratory information system. The largest among these is the hospital information systems segment, pegged to expand at a CAGR of 6.9% from 2013 to 2019. Likewise, by delivery mode, the market is classed as: On-premise technology, web-based technology, and cloud technology. The report also segments the healthcare information systems market by components as: Hardware, software, and services.

Browse the full Press Release : http://www.transparencymarketresearch.com/pressrelease/healthcare-information-system.htm

On the basis of geography, the healthcare information systems market is classified as North America, Asia, Europe, and Rest of the World (RoW).While North America is the global leader in the healthcare information systems market, Asia will report the healthiest rate of growth over the report’s forecast period, say TMR analysts. The Asian healthcare information systems market will benefit from developments in India, China, and Japan, whereas in North America, the United States will continue to fuel the market’s progress.The competitive landscape of the healthcare information systems market is still in a phase of change and growth, but is currently dominated by GE Healthcare. The other players that have an appreciable share in the market’s revenue are McKesson Corporation and Philips Healthcare.

The global healthcare information systems market is segmented as follows:

Healthcare Information Systems Market, by application mode

Hospital Information System

Pharmacy Information System

Laboratory Information System

Healthcare Information Systems Market, by delivery mode

Web based technology

On-premise technology

Cloud based technology

Healthcare Information Systems Market, by components

Software

Hardware

Services

Healthcare Information Systems Market, by geography

North America

U.S.

ROW

Asia

Japan

China

Europe

U.K.

Germany

France

Rest of the World (RoW)

Request a Sample of this Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1457

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket Ghumare

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Laboratory Information Systems (LIS) Market to Value US$2,158.0 Billion by 2019 due to Hospitals Prioritizing for LIS

The featured report from Transparency Market Research (TMR) on the global laboratory information systems (LIS) market states that the market will grow at a moderate CAGR of 7.7% during the forecast period from 2013 to 2019. This report is titled “Laboratory Information System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”.The global laboratory information systems (LIS) market was estimated at US$1,381.4 billion in 2013 and is projected to be worth US$2,158.0 billion by 2019.Laboratory information systems (LIS) allow clients to access, record, manage, store, and recover laboratory information. The growing demand for improved laboratory efficiency along with hospitals prioritizing for LIS will drive this market. The global laboratory information systems market will also benefit from the rising government support, growing need for integrated healthcare information systems (HIS), and accelerating investment from market players.

Browse Full Report Laboratory Information System Market http://www.transparencymarketresearch.com/laboratory-information-systems.html

On the contrary, the shortage of experienced professionals, interoperability issues, coupled with the high maintenance and service expenses will suppress the global laboratory information systems market. Nonetheless, LIS module is at an evolutionary stage and players in the market are providing LIS solutions that address to each hospital’s needs. LIS need to be developed, customized, and configured considering the requirements of a laboratory.Hospitals are pressing for elevated reimbursement, as market forces from government are seeking to cut down on costs. Automated hospital management systems such as LIS hold the potential to make care delivery much more efficient. However, the escalating healthcare costs are a major concern for insurers and the government.Application mode-wise, the global laboratory information systems market is segmented into drug delivery LIS and clinical diagnostics LIS. The clinical diagnostics laboratory information systems segment held the largest market share and is expected to grow at an 8.9% CAGR during the forecasting horizon.

Browse Full Press Release :http://www.transparencymarketresearch.com/pressrelease/laboratory-information-systems-market.htm

Delivery-mode wise, the global laboratory information systems (LIS) market is divided into on-premise, web-based, and cloud-based. Component-wise, the global laboratory information systems market is classified into hardware, software, and services.Region-wise, the global laboratory information systems (LIS) market is divided into Europe, North America, Asia, and RoW. North America leads the global laboratory information systems market. Increasing instances of lethal injections and their diagnosis and treatment are some of the factors driving this regional LIS market. This regional market for LIS also benefits from the funding from public money. Europe is the fastest developing LIS market. Country-wise, some of the fastest developing LIS market includes Japan, Germany, the U.S., and the U.K.

Innovation will drive the global laboratory information systems market. Companies in this market are investing in testing prototypes of LIS hubs, which work from a remote location.At present, McKesson Corporation is the leading market player. Other key companies operating in the global laboratory information systems market are Merge Healthcare, Cerner, Thermo Fisher Scientific, 3M Health Information Systems, Labware, and Autoscribe Informatics.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1482

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Increased Pharmaceutical Research and Growing Patient Population to Drive Global Clinical Trial Management System Market

Clinical trial management system (CTMS) is an end-to-end software solution for planning, development, execution, and charting of clinical trials, which also includes participant information, trial and registration deadlines, and other landmark events.CTMS helps research centers and life sciences organizations attain efficacy and enhanced productivity of clinical trials by facilitating and managing clinical trials. Integrating CTMS with health information systems (HIS) leads to accuracy and economic benefits such as time and human resource saving, one of the primary factors to drive growth of the CTMS market.Additionally, high incidence of diseases has led to increased R&D activities in pharmaceutical, bio sciences, and clinical research sectors, which is offering several opportunities for the CTMS market. The global CTMS market was valued at US$844 million in 2013 and will exhibit an impressive 14% CAGR from 2013 to 2019 to reach US$1848.5 million in 2019.

Browse Full Global Clinical Trial Management System Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html

Software Sub-Segment to Dominate Global Clinical Trial Management Systems Market

The CTMS market is segmented on the basis of delivery modes of CTMS solutions, end users, types of CTMS solutions, components of CTMS solutions, and regional markets.Web-based CTMS solution delivery accounts for the highest revenue generation in the CTMS market. Of all the end users, the pharmaceutical sector accounts for the largest share of the CTMS market. On the basis of components of CTMS solutions, the software segment accounts as the lead revenue generator. The software segment of the market was valued at US$585 million in 2013 and is expected to reach US$1,274.2 million in 2019, growing at a healthy 13.9% CAGR between 2013 and 2019.

State-Funded Clinical Trials and Research to Allow U.S. to Lead Global CTMS Market

In terms of geography, North America accounts as the most active regional market in the overall CTMS market. This is due to the fact that North America has traditionally been supportive to clinical trials and clinical trials in the U.S. are being funded by the National Institute of Health (NIH), academic institutions, government agencies, and healthcare organizations. As per statistics by the U.S. National Institute of Health, approximately 56,981 clinical trials were conducted in the U.S. in 2011.The North American clinical trial management system market will be valued at US$1107.5 million in 2019, increasing from US$514.4 million in 2013, exhibiting a CAGR of 13.6% from 2013 to 2019.

Browse Full Press Release: http://www.transparencymarketresearch.com/pressrelease/clinical-trial-management-systems-market.htm

Improved Drug Patent Expiration Laws to Propel Asia Pacific CTMS Market

In Europe, mainly in Central European and East European countries, bio sciences and pharmaceutical companies receive abundant support to conduct clinical trials. The CTMS market has consequently grown considerably in the early parts of the ongoing decade and is expected to stay on a strong growth trajectory in the coming years.However, Asia Pacific is poised to be the fastest growing regional segment of the clinical trial management systems market. Escalated medical research and development in the pharmaceutical sector has led to adoption of CTMS in the region. Moreover, improved industry regulatory framework and patent expiration statutes in several countries such as China, India, and Japan have contributed significantly to the growth of the CTMS market in Asia Pacific.Some of the leading companies in the global clinical trial management system market are Oracle Corporation, Merge Healthcare, PAREXEL, and Medidata Solution. Other players offering services in the market are BioClinica, eClinforce, Forte Research, MedNet Solutions, Bio-Optronics, and DSG.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=544

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Nachiket

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com